Volume | 14 |
|
|||||
Noticias | - |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Astrazeneca Plc | 0A4J | London | Acción Ordinaria |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
Operaciones | Volume Operado de la Acción | Volumen promedio |
---|---|---|
15 | 14 | - |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
04:54:31 | O | 3 | US$ 75.50 | USD |
Información Financiera Astrazeneca Plc 0A4J
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
US$ 0.00 | - | - | - | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Astrazeneca Plc 0A4J
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
02/1/2024 | 09:00 | UK Regulatory | AstraZeneca PLC Total Voting Rights |
27/12/2023 | 01:00 | UK Regulatory | AstraZeneca PLC AstraZeneca acquires Gracell |
22/12/2023 | 01:00 | UK Regulatory | AstraZeneca PLC Wainua (eplontersen) granted first US FDA.. |
14/12/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Director/PDMR Shareholding |
12/12/2023 | 01:05 | UK Regulatory | AstraZeneca PLC AstraZeneca to acquire Icosavax |
01/12/2023 | 09:05 | UK Regulatory | AstraZeneca PLC Block listing Interim Review |
01/12/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Total Voting Rights |
01/12/2023 | 01:00 | UK Regulatory | AstraZeneca PLC Discontinuation of two CRYSTALIZE evidence.. |
23/11/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Director/PDMR Shareholding |
17/11/2023 | 01:00 | UK Regulatory | AstraZeneca PLC Truqap approved in US for HR+ breast cancer |
14/11/2023 | 01:05 | UK Regulatory | AstraZeneca PLC Update on PACIFIC-2 Phase III trial for.. |
09/11/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Director Declaration |
Histórico de Datos 0A4J
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |